Sakir Humayun Gultekin, M.D., has joined Sylvester Comprehensive Cancer Center and the Department of Pathology & Laboratory Medicine at the University of Miami Miller School of Medicine and UHealth. Gultekin will serve as Director of Clinical and Molecular Neuropathology for the University of Miami Brain Tumor Initiative, where he will support its comprehensive brain tumor program via clinical and basic science research.
Renal Pathology ServiceMore info
40th REVIEW AND ADVANCES IN PATHOLOGYMore info
Among the Nation’s BestLearn More
Dedicated to Providing Quality Patient CareLearn More
Providing the Highest Quality EducationLearn More
A new study by prostate cancer researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has characterized the active surveillance criteria in Hispanic men, marking the first such study in this population.
A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple-negative breast cancer (TNBC), which has generally been unresponsive to hormone receptor-targeted treatments, can indeed be treated using vitamin D and androgen receptor-targeted therapy. The discovery offers a new treatment option beyond chemotherapy.